Abstract: Schizophrenia patients display decreased synaptic density in postmortem studies, suggesting aberrant microglial synapse elimination during neurodevelopment. Here, we use cellular reprogramming to create patient-specific in vitro models of microglia-mediated synapse engulfment that demonstrate increased synapse elimination in schizophrenia-derived models compared to healthy controls. We show that excessive synaptic pruning in schizophrenia reflects abnormalities in microglia-like cells as well as synaptic structures. Further, we find that schizophrenia risk-associated variants within the complement component 4 locus contribute to the increased uptake in schizophrenia models. Finally, we demonstrate that the antibiotic minocycline reduces microglia-mediated synapse uptake and show that minocycline treatment for acne is associated with a reduction in incident schizophrenia risk compared to other treatments in a cohort of more than 9,000 young adults drawn from health records. Specific pharmacological interventions targeting excessive pruning merit further study for their capacity to delay or prevent the onset of schizophrenia in high-risk individuals.
INTRODUCTION
Schizophrenia is a heritable psychiatric disorder with disabling psychotic and cognitive symptoms 1 . Disease mechanisms remains largely elusive despite the identification of more than 100 regions of the genome associated with schizophrenia liability 2 , repeated imaging studies displaying reduced grey matter thickness as well as abnormal functional connectivity [3] [4] [5] [6] [7] [8] [9] [10] [11] , and postmortem studies reporting reduced numbers of synaptic structures [12] [13] [14] . The most strongly associated locus for schizophrenia in meta-analysis of genome-wide association data involves structurally distinct alleles of the complement component 4 (C4) genes 2 , with each allele associated with schizophrenia risk in proportion to its effect on C4A expression 15 , and rodent studies suggest a pivotal role for complement signaling in microglia-mediated elimination of synapses in the developing visual system [15] [16] [17] . Given the extensive elimination of synapses in human cerebral cortex during late adolescence and early adulthood 18 , i.e., the time-period in which schizophrenia symptoms usually become clinically evident 1 , it has been suggested that excessive synaptic pruning by microglia contributes to the observed reduction in synapse density among schizophrenia patients 15, 19 . However, the inability to model microglial functions in human using patient-derived cells has limited efforts to directly link excessive microglial synapse elimination to schizophrenia pathology. Mouse models cannot fully address this question, as the rodent genome does not code specialized C4A and C4B genes, and human microglia differ markedly from their rodent counterparts, with a higher expression of complement components as well as several genes important in brain development 20 .
We have recently developed and validated high-throughput methods for modeling synaptic pruning in vitro using patient-derived cells 21 . Similar to recent induced pluripotent stem 4 cell (iPSC)-derived microglia-like cells [22] [23] [24] [25] , human monocytes cultured under conditions resembling the central nervous system (CNS) microenvironment recapitulate important traits of primary human microglia including a ramified morphology, expression of genes highly enriched in acutely isolated microglia (e.g., P2ry12, C1qa, Gas6, Mertk, Gpr34, and Pros1), and clustering with primary fetal microglia rather than peripheral monocyte-derived macrophages 21 .
Mimicking primary fetal microglia, induced microglia-like cells (iMGs) under serum-free in vitro conditions engulf synapses isolated from induced iPSC-derived neural cultures using a complement 3 receptor (C3R)-dependent mechanism 21 . By using live-imaging, as well as confocal microscopy, we have been able to develop robust methods for quantification of synapse uptake 21 .
In this study, we show that co-culture of iMGs with differentiated human neurons results in decreased spine density, and that iMGs display an increased uptake of isolated synaptic structures from schizophrenia-derived neurons compared to those from healthy controls (HCs).
Further, increased synapse elimination among schizophrenia patients can be attributed to both the target synaptic structures as well as iMG function, and these effects are modified by, but not fully accounted for, variation within C4A and C4B present in the neural cultures. Finally, we demonstrate that minocycline, a second-generation tetracycline with high brain penetrance, reduces synapse uptake in vitro in a dose-responsive fashion. In electronic health records we likewise detect the predicted reduction in incident schizophrenia risk associated with minocycline exposure among acne-treated adolescents compared to other antibiotics.
RESULTS

Patient-derived microglia-like cells
To derive iMGs from schizophrenia subjects and matched HCs, monocytes were isolated from blood drawn from male individuals with schizophrenia and age-matched male HCs. Briefly, microglial induction was achieved by exposure to interleukin (IL)-34 and granulocyte macrophage colony stimulating factor (GM-CSF), under serum-free culture conditions, on an extracellular matrix (ECM) resembling astrocyte-derived ECM, containing laminin, collagen and entactin 21 . No major differences in morphology could be observed between patient and control derived cultures with the vast majority of cells displaying a ramified morphology resembling resting-state microglia (Fig. 1a) , and expressing microglia markers such as P2ry12, TMEM119, and PU.1 (Fig. 1b) . To further characterize iMGs we performed transcriptome analyses comparing mRNA expression levels in iMGs to matched monocytes ( Fig. 2 ). In comparison to monocytes (P < 0.0001), as well as to ordinary monocyte-derived macrophages (P < 0.0001), iMGs displayed a strong enrichment of microglia-specific genes (based on two gene sets of published microglia-specific genes in acutely isolated microglia 20, 26 ; Supplementary Tables 1, 2, 3 and 4) among upregulated genes (fold change > 20), with iMGs significantly clustering apart from monocytes and monocyte-derived macrophages ( Fig. 1e and Supplementary Fig. 3 [displaying a hierarchical cluster analysis with uncertainty in clustering assessed by multiscale bootstrap resampling]). Corroborating our previous observations with isolated synapses from HCs 21 , we also noted a clear decrease in spine density after co-culturing iMGs with iPSC-derived neural cultures ( Fig. 1f and 1g ) while total numbers of neurons were unchanged.
Isolation of active synapses from human iPSC-derived neural cultures
To model interactions between synapses and microglia in schizophrenia, we collected and reprogrammed iPSCs (Fig. 2a, and Supplementary Fig. 4 ) from dermal fibroblasts from male subjects with schizophrenia and age-matched HC donors, with clinical status confirmed by structured clinical interview, using an integration-free and all-synthetic RNA-based reprogramming system as previously described 27 . Purified and expandable neural progenitor cells (NPCs) were derived from these iPSCs using a neural induction supplement based on defined small molecule induction 28 , followed by magnetic-activated cell sorting (PSA-NCAM + , CD271 -, CD133 + ) and verified by immunocytochemical analyses for standard NPC markers (Fig. 2b) . We then performed an inclusive neural differentiation by mitogen removal resulting in mixed populations of neural subtypes including telencephalic cortical (Fig. 2c, 2d , and Supplementary Table 5 ) 29, 30 . To be able to model interactions between iMGs and synapses in patients vs. HCs, we then proceeded with isolation of synaptosomes, i.e., synaptic nerve terminals. As we have previously shown, iPSC-derived neural cultures yields a highly purified synaptosome preparation compared to isolation from postmortem human brain 21 . Briefly, neural cultures were harvested, homogenized and purified using Syn-PER Synaptic Protein Extraction Reagent (Thermo Scientific), which was followed by repeated centrifugal fractionation. In addition to previous validation of iPSC-derived synaptosomes using western blotting analyses for enrichment of synaptic markers 21 , we now confirmed that synaptosomes after freeze-thaw exhibited canonical structural and functional synaptic properties by using transmission electron microscopy (TEM; Supplementary Fig. 5 ), labeling for active synaptic vesicle endocytosis (SVE) upon depolarization ( Fig. 2e ) 31 , and fixation followed by staining for the post-synaptic 7 marker PSD-95 (Fig. 2e) . These investigations confirmed specificity of the synaptosome extraction procedure as well as functionality of isolated and freeze-thawed synaptosomes, and further enabled control for line-specific differences of synaptosome yield in functional assays.
Increased engulfment of synapses in disease models -effect of potential confounding variables and C4-HERV copy numbers
We first compared overall phagocytosis in models incorporating iMGs and synaptosomes derived from 3 males with schizophrenia to models derived from 2 age-matched male HCs in real-time live imaging using synaptosomes labeled with a pH-sensitive dye (pHrodo ® ) that binds non-specifically to proteins and exclusively fluoresces bright red in the post-phagocytic phagolysosome compartments (Fig. 3a) . Each synaptosome line was assessed with iMG cultures from at least 4 different subjects (in total, iMGs from 13 schizophrenia patients and 13 HCs) matched on age. Quantification of bright red fluorescence, indicating cellular uptake of pHrodolabeled synaptosomes, revealed significantly increased phagocytosis in schizophrenia-derived iMG cultures compared to matched HC iMG cultures (P < 0.0001; Fig. 3b ). As previously described 21 , the vast majority of bright red fluorescence also stained positive for the postsynaptic marker PSD-95 (Fig. 3c) confirming that we detected a specific engulfment of synaptosomes. Using confocal microscopy we quantified phagocytic inclusions (PSD-95 + inclusions, 0.5-1.5 µm) in these cultures (excluding 2 iMG culture in which immunohistochemistry failed because of technical issues), as well as another set of iMG cultures consisting of 8 schizophrenia models and 6 HC models (iMG derived from 2 subjects with schizophrenia and 4 HCs, and synaptosomes derived from 2 schizophrenia subjects and 2 HCs).
In agreement with real-time live imaging data, experiments quantifying PSD-95 + phagocytic 8 inclusions using confocal microscopy confirmed an increased uptake in schizophrenia-derived models (P = 0.021; Fig. 3d ).
To address potential clinical confounding variables, we first examined IQ as it was significantly lower in the schizophrenia group (see also Supplementary If structural variation within C4A and C4B increases risk of schizophrenia via more extensive tagging of synapses by C4A, in turn leading to increased pruning, we reasoned that an effect of such genetic variation would influence overall synapse engulfment in our in vitro assay.
We therefore used digital droplet PCR (ddPCR) to determine total copy numbers of C4A and C4B with human endogenous retroviral (HERV) insertion (C4-HERV [C4L]); shown to accurately predict schizophrenia risk originating from this locus as well as C4A over C4B expression 15 . As previously described, synaptosomes prepared from astrocyte-conditioned medium (ACM) treated iPSC-derived neural cultures contains C4 protein (Supplementary Fig.   6 ). Stratifying PSD-95 + uptake in the total of 19 schizophrenia models and 19 HC models dependent on C4-HERV copy numbers (in neural lines used to isolate synaptosomes) we observed a higher uptake with increasing C4-HERV copy numbers (Fig. 3e ) independent of total C4 copy numbers (β = 0.025 [P = 0.0023] and adjusted β = 0.038 [P = 0.00037], respectively).
We also observed an interaction between C4-HERV copy numbers and case status predicting higher PSD-95 + uptake (β = 0.043 [P = 0.0034]). The effect remained after adjusting for C4-
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HERV copy numbers and total C4 copy numbers in matched iMGs (β = 0.042 [P = 0.022] while C4 haplotypes of iMGs had no impact on PSD-95 + uptake (C4-HERV; P = 0.99 and C4 total; P = 0.87, respectively).
Confirming our prior observations 21 , engulfed synaptosomes (indicated as PSD-95 + inclusions) also strongly co-localized with C4 + puncta (Costes' P value for colocalization = 1; Fig. 3f ), thereby further supporting that engulfed synaptosomes were largely tagged by C4A. In line with this observation, schizophrenia models displayed increased uptake of C4 + synaptosomes (P<0.0001; Fig. 3g ).
Microglial factors influence synapse engulfment independent of neural phenotype
In order to better dissect the individual contributions of synaptosomes and iMGs toward the observed increase in phagocytic uptake of patient-derived synaptic particles, we repeated phagocytosis experiments but now crossing schizophrenia-derived synaptosomes with iMGs from a subset of individuals with schizophrenia as well as with synaptosomes from matched HCs. Specifically, we compared synapse elimination in "pure" disease models, i.e., iMG cultures from 8 subjects with schizophrenia matched with synaptosomes from 2 subjects with schizophrenia, with "crossed" or "mixed" models in which the same synaptic structures from schizophrenia subjects were added to iMGs derived from 8 matched HCs, as well as to matched "pure" control models (synaptosomes derived from 3 HCs; Fig. 4a) . These experiments revealed a distinct and significantly decreased uptake of diseased synaptosomes when switching from schizophrenia-to HC-derived iMG (real-time live imaging: P < 0.0001; Fig. 4b , and confocal microscopy [PSD-95 + puncta] as well as C4 + puncta: P = 0.031; Fig. 4c and Fig. 4d ), while in agreement with concurrent neural specific effects an increased uptake remained in mixed models compared to pure HC models. That is, both neural and microglial factors contribute to the overall increased uptake of synaptic structures in our schizophrenia models.
Minocycline decreases synapse engulfment in vitro
Minocycline, a semisynthetic brain-penetrant tetracycline antibiotic, has been suggested to be beneficial in neurodevelopmental and neurodegenerative diseases because of putative antiinflammatory effects 32 . While the mechanism of action is unknown, it has been postulated that minocycline works by targeting synaptic remodeling 33 . Consistent with this hypothesis, repeated high-dose intraperitoneal administrations of minocycline in postnatal mice cause a decrease in engulfment of retinal ganglion cells (RGC) inputs; a commonly used rodent model for synaptic pruning 17 . Clinically, however, minocycline is typically given in lower doses, yielding significantly lower brain concentrations 34, 35 , and human cellular data is lacking. Guided by previous rodent studies 36,37 we pre-treated iMG cultures with minocycline in a series of clinically relevant doses (1 µM, 10 µM, and 60 µM). Real-time live imaging revealed a dosedependent decrease in engulfment of synaptosomes with nearly undetectable synaptosome uptake at 60 µM (P < 0.0001; Fig. 5a ).
Drug exposure during adolescence and risk of later-on schizophrenia
As our data demonstrated that minocycline dose-dependently decreases microglial engulfment of synaptic structures in human models at clinically relevant doses, we hypothesized that chronic exposure to minocycline, or the chemically and mechanistically-similar brain-penetrant drug doxycycline, during adolescence, i.e., a time-period of intense synaptic pruning 18 , might decrease schizophrenia risk. These two medications are among several antibiotics commonly prescribed for treating acne vulgaris 38 , allowing a pseudo-randomized investigation using the electronic health records of a large academic medical center. Given the challenges in terms of feasibility of prospective randomized studies, we sought to identify proof-of-concept that might motivate such next-step investigation. To avoid confounding by indication, we analyzed 9,031 individuals age 18 or younger, treated for acne but without a prior diagnosis of schizophrenia or 
DISCUSSION
Applying cellular reprogramming methods to create patient-specific models of synaptic pruning in individuals with schizophrenia and carefully matched HCs, we demonstrate robust support for increased elimination of isolated synapses among schizophrenia-derived iMG cultures, attributable independently to neural as well as microglia-specific effects inhibited in a dosedependent fashion by minocycline. We further report proof-of-concept clinical data in a large cohort of antibiotic-treated young adults with acne identified in electronic health records supported a reduction in incident schizophrenia risk following chronic minocycline but not other antibiotic exposure during adolescence, after adjustment for potential confounding variables.
Our experimental data using patient-derived cells offer a potential mechanism explaining structural and functional disturbances observed in schizophrenia patients. Loss of cortical gray matter volume among schizophrenia patients has been repeatedly observed 39 . Decreased synaptic density has been reported from postmortem material [12] [13] [14] and functional magnetic resonance imaging (fMRI) studies display aberrant functional brain connectivity [9] [10] [11] 39 . Studies of 'at risk' adolescence or early adulthood populations further reveals strong evidence for an accelerated decrease in gray matter thickness among 'converters' [3] [4] [5] [6] [7] [8] , suggesting that the observed structural aberrations are presented already at transition to illness and are likely to be related to disturbance in cortical maturation in the given age interval. Rodent studies demonstrate that microglia, dependent on complement signaling, play a major role in synaptic pruning 16, 17, 40 , a prominent feature of human neurodevelopment during adolescence 18 , while microglial 13 activity, as measured by [ 11 C]PBR28 positron emission tomography (PET) scans, correlate to cortical gray matter loss in subjects at ultra-high risk of psychosis 41 .
In line with data from mice deficient in C4 15 , sharing sequence similarities to both human C4A and C4B, we observed a strong correlation between a schizophrenia risk variant, linked to increased C4A expression, and increased synapse engulfment. By combining synapses and iMGs from subjects with different C4 haplotypes we were also able to specifically link the effect of genetically predicted increased C4A over C4B expression (controlled for total C4 copy numbers) to neurons. While C4 risk variants exclusively influenced synapse elimination through a neural mechanism we also observed effects on synapse engulfment through C4-independent effects related to intrinsic factors in iMGs. Notably, drug targets that are specifically expressed in microglia may be more favorable in terms of adverse immune effects, and studies aiming to identify such targets are warranted. Pre-treating iMGs with the antibiotic minocycline we observed a dose-dependent decrease of synaptosome uptake. This first observation in our human model system accords with a previous animal study reporting decreased engulfment of RGC inputs among mice treated with minocycline 16 . Engulfment of viable neural progenitor cells, a microglial function that we have previously shown can be mimicked in vitro by iMGs 21 , is also inhibited by minocycline using a rodent model in which an induced status epilepticus increases numbers of progenitors in the subgranular zone of the dentate gyrus 42 . In contrast, minocycline does not decrease phagocytosis of amyloid β fibrils in precursor protein transgenic (APP-tg) mice 43 , although it prevent secretion of pro-inflammatory cytokines 43 , and even rescues decreased engulfment of latex beads by adult hippocampi microglia isolated from Polyinosinic:polycytidylic acid (Poly(I:C)) mice 44 . Taken together, this work demonstrates that 14 minocycline influence microglial phagocytic function in a highly complex but dissectible manner where factors such as activation state and given substrate may be of crucial importance.
Our pseudo-randomized investigations using electronic health records revealed a decreased risk of incident schizophrenia after chronic exposure to minocycline but not nontetracycline antibiotics during adolescence. This finding requires confirmation in prospective randomized trials, which may be challenging in terms of feasibility but are warranted by our results. Previous clinical studies have yielded mixed effects for minocycline in small-scale clinical investigation, but importantly these studies only examined acute efficacy in chronic schizophrenia subjects. Our results suggest that minocycline has the capacity to delay, or even prevent, the onset of schizophrenia through modulation of microglia-mediated synaptic elimination. Such an effect would be of major clinical importance if confirmed prospectively, as it would represent the first demonstrated means of preventing this chronic and disabling disorder.
These studies, perhaps coupled with in vitro investigation using our model, represent an important next step.
Several limitations in the current study should be highlighted. First, the transcriptomic signature of human ex vivo microglia changes rather rapidly in vitro 20 . iMGs, similar to recent iPSC-derived microglia-like cells and primary cultured microglia, do not fully recapitulate the molecular signature of human ex vivo microglia despite adjusting conditions to mimic the brain microenvironment. However, despite these limitations our in vitro assays using iMGs were still able to recapitulate mechanisms observed in vivo using rodent models 21 . It is also worth noting that the current study lacks direct evidence supporting that the observed effects of minocycline in vitro are per se causing the decreased incidence of schizophrenia observed in our register-based analyses. We intend the latter as proof-of-concept, but can only demonstrate association using this design. Although the time-period of minocycline exposure overlaps with cortical maturation due to extensive synaptic pruning it is fully possible that minocycline reduces risk of schizophrenia through another as-yet unidentified mechanism.
Nonetheless, taken in aggregate, our work supports increased synapse elimination in schizophrenia, offering a mechanism linking genetic risk variants to observed structural brain changes in early disease. Specific pharmacological interventions targeting microglial elimination of synapses merit further study for their capacity to delay or prevent the onset of schizophrenia in high-risk individuals.
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ONLINE METHODS
Study design
For patients vs. controls comparison of synaptosome uptake by iMGs, using live-imaging, we assumed a between-subject effect size of 0. Supplementary Table 6 .
Generation of induced microglia-like cells (iMGs)
iMGs were derived from monocytes using established methods as previously described in detail 21 , but with some modifications. Briefly, peripheral blood mononuclear cells (PBMCs) generated from whole blood were rapidly thawed at 37°C and diluted into pre-warmed RPMI-1640 medium (Sigma-Aldrich, Saint Louis, MO, USA; #R0883-500ML) with 10% heat-inactivated low-endotoxin FBS (Rockland Immunochemicals, Hamburg, Germany; #FBS-01-0100) and spun at 300 x g for 5 minutes (break off). The supernatant was aspirated completely and the pellet was resuspended in RPMI-1640 medium (Sigma-Aldrich) with 10% heat-inactivated lowendotoxin FBS and 1% penicillin-streptomycin (P/S). Cells were plated onto Geltrex (Thermo Fisher Scientific, Waltham, MA, USA; #A1048002) coated 24 well plates at a density of 1 x 10 6 cells per well and incubated overnight at 37°C. Media was then changed to RPMI 1640 medium with Glutamax (Life Technologies, Carlsbad, CA, USA) with 1% P/S, 0.1µg/ml of IL-34 (R&D systems, Minneapolis, MA, USA: #5265-IL-010) and 0.01ug/ml of GM-CSF (R&D systems, #215-GM-010/CF). After 10 days the plates were washed thoroughly to remove unbound cells and fresh media was added. Cells were harvested or used for functional assays the following day. supplemented with B-27 (Invitrogen) with medium replacement every 3-5 days for 6 weeks.
Collecting dermal biopsies and establishing fibroblast cultures
Global gene expression microarray hybridization and data analyses
Cells were harvested using Accutase and pelleted by centrifugation at 300 x g. The supernatant was removed and the pellets were stored at -80°C. Total RNA was extracted using the RNeasy Mini kit (Qiagen, Hilden, Germany) as per manufacturer's instructions and concentrations and 260nm/280nm readings were determined using a NanoDrop monocytes and monocyte-derived macrophages (Supplementary Fig. 3 ) we applied bootstrap resampling (10,000 iterations) via the R package pvclust. For each suggested cluster pvclust provides two types of P-values: the Bootstrap Probability value from the ordinary bootstrap resampling and the Approximately Unbiased (AU) probability value from multiscale bootstrap resampling. The multiscale bootstrap resampling method was introduced to develop an approximately unbiased test, and therefore it provides better estimations of the probability values 34 . The standard errors of AU P-values were also plotted against AU P-values with no indication of sampling error.
Synaptic vesicle endocytosis and synapse markers in isolated nerve terminals
With some modifications, we adopted the methods of Daniel et al. and adjusted at pH 7.4) was pre-warmed at 37°C and infused with 5% CO 2 for 30 minutes. After centrifugation of synaptosomes, SET buffer was carefully removed using a multichannel pipette and 60µl of HBK buffer was added. The synaptosomes were then incubated at 37°C for 15 minutes to acclimate to HBK. Simultaneously, a solution of 1.5µM Calcein Blue-AM (Invitrogen, #C1429) was prepared in HBK buffer. After incubation, HBK buffer was carefully removed and Calcein Blue-AM (60µl per well) was added followed by incubation for 30 minutes at 37ºC in the dark. FM4-64 dye (Invitrogen, #T13320) was diluted 1:100 in water for unstimulated control wells, and diluted 1:100 in 400mM KCl for stimulated wells. These solutions were protected from light. After incubation with Calcein Blue-AM, synaptosomes were removed from the incubator and the solutions were carefully replaced with 81µl of HBK buffer.
Starting with the wells for unstimulated controls, 9µl of the unstimulated solution was added to the unstimulated wells, followed by 9µl of stimulated solutions for the stimulated wells, using a multichannel pipette. The plate was incubated for two minutes at 37ºC. Media was aspirated carefully with a pipette and replaced by 81µl of HBK buffer and 9 µl of ADVASEP-7 (SigmaAldrich, St. Lois, MO, USA, #A3723) was added to stop the depolarization and wash off the excess FM4-64 from the plasma membranes. The plate was incubated for another two minutes at 37ºC, after which ADVASEP-7 solution was replaced by 90µl of HBK using a multichannel pipette. The plate was then immediately imaged using an IN Cell 6000 confocal analyzer (GE Healthcare). 40 randomly selected images were acquired per well with all settings kept constant between conditions. After Imaging, plates were fixed with 4% PFA for 15 minutes at room To makes sure that our main analyses were not substantially influenced by selective bias due to differences in harvested synaptosome counts, we also performed all main analyses adding these counts as covariates (multiple logistic regression).
Given limited line-to-line variability with a random distribution between cases and controls, all adjusted analyses displayed similar effect sizes and significances for the different phagocytic index (data not shown).
Transmission electron microscopy (TEM)
Isolated synaptosome suspensions were fixed with 2.0% glutaraldehyde in 0.1M sodium phosphate buffer (pH 7.4, Electron Microscopy Sciences, Hatfield, PA, USA) for two hours at room temperature, then centrifuged at 14 000 rpm for 10 minutes to obtain a working pellet.
Pellets were infiltrated in 1.0% osmium tetroxide in cacodylate buffer for one hour at room temperature and gently rinsed several times in cacodylate buffer. Pellets were stabilized in 2% agarose, and agarose blocks (containing pelleted material) were dehydrated through a graded series of ethanols to 100%, then dehydrated briefly in 100% propylene oxide. Specimens were pre-infiltrated for two hours in 
Co-culture system
Co-culture experiments were conducted with iPSC-derived neurons following a 90-day cortical neural differentiation protocol adapted from previously described 48 . Briefly, iPSCs were grown in N2B27 supplemented neurobasal medium containing LDN 193189 (100 nM; Stemgent, USA)
and SB 431542 (10 µM; Stemgent, USA) with daily media changes for 10 days then switched to N2B27 medium alone for the remainder of the differentiation. Neural cultures were replated into 24 well plates at a density of 2.5 x 10 4 cells / cm 2 in 0.5 mL N2B27 on day 80 and further cultured for 10 more days. Neurons were pHrodo labeled for one hour at 37ºC followed by a media change. Mature iMGs were detached from plates using Accutase and added to neural cultures. The co-culture plates were then imaged using Incucyte ZOOM live-imaging system (Essen Biosciences) with images collected every 4 hours for a period of 48 hours. After assay, 
Isolating and labeling nerve terminals
24 hours before harvesting neural cultures by scraping, medium was changed to ACM (ScienCell, Carlsbad, CA, USA). Synaptosomes were then isolated as previously described using Synaptic Protein Extraction Reagent (Syn-PER; Thermo Fisher Scientific) 21 . Resulting synaptosomes were collected and labeled with an amine-reactive and pH-sensitive dye (pHrodo Red, SE; Thermo Fisher Scientific; #P36600) as per manufacturer's instructions.
Western blotting analyses
Synaptosomes were centrifuged at 12000 x g for 15 minutes and pellets were re-suspended in to confirm that the synaptosomes were positive for typical synaptic markers.
Real-time live imaging
We used a live cell imaging system, Incucyte ZOOM system (Essen Biosciences) incubated at 37°C and 5% CO 2 , as previously described 21 , but with some modifications regarding image analyses. Briefly, sonicated and pHrodo labeled synaptosomes were added to iMG cultures on 24-well plates and imaged at a resolution of 0.61µm/pixel. Images (1392x1040 pixels) were further pre-processed in IncuCyte ZOOM software (2016A) and exported as 16 bit grayscale PNG files. For minocycline experiments, iMGs were pretreated with 1µM, 10µM, 60µM, or vehicle for 30 minutes before initiation of the phagocytosis assay. Data was further analyzed in MATLAB (MathWorks, R2014b) to quantify phagocytized particles. Briefly, unsharp masking using a 35 pixels standard deviation Gaussian filter was used to remove background from the images, followed by distribution-based thresholding. For each image, the threshold was calculated as 10 standard deviations above the average value for the local maxima. A threshold was applied to the resulting segmented regions to remove particles smaller than 10 pixels in area.
The area of the remaining particles was summed to produce the total amount of phagocytized particles. This sum was divided on number of iMGs per image and represents phagocytic index.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (PFA) for 15 minutes at 4ºC. After fixation, cells were washed two times with PBS and then blocked for one hour with a solution containing 5% FBS and 0.3% triton in PBS. Cells were then washed three times for 5 minutes each with 1% FBS in PBS and incubated with primary antibodies (details in Supplementary Table 7) for two hours at room temperature. After incubation, the cells were washed three times for 5 minutes each with 1% FBS PBS and incubated for one hour at room temperature in mixture of appropriate secondary antibodies (1:500) and Hoechst (1:5000) diluted in 5% FBS in PBS. Cells were then washed again three times for 5 minutes each with 1% FBS in PBS and imaged. Antibody specificity was confirmed by performing 'secondary only' experiments (data not shown).
Confocal microscopy
Images were acquired using an IN Cell 6000 analyzer (GE Healthcare). 20 randomly selected images were acquired per well (24-wells plates) with all settings kept constant between different conditions. Quantification was performed using the IN Cell Analyzer 1000 (GE Healthcare).
Nuclei were identified using a Top-Hat transform, while cells were identified using Region Growing segmentation. PSD-95, pHrodo, or C4 + particles were identified using a multiscale Top-Hat transform (10 transformations), a size filter of 0.5-1.5µm, minimum sensitivity for detection of inclusions, and restriction of detection of inclusions to cytoplasm area. For outcome measurements we counted number of identified particles per iMG cell and divided on cytoplasm area to create a phagocytic index. The mean of phagocytic indexes for all images per well was then used in further analyses.
Molecular analyses of C4 alleles
Similar to Sekar et al. 15 , we measured copy numbers of each individual C4 structural allele (C4A, C4B, C4L, and C4S) using ddPCR, on genomic DNA isolated from blood samples from a total of 130 controls and 54 patients with schizophrenia from the MGH Neuropsychiatric
Biobank. In summary, 50ng of genomic DNA was fragmented by digestion with the restriction enzyme AluI 15 . Copy numbers of C4A, C4B, C4L and C4S were then quantified from genomic DNA using digital droplet PCR on a QX200™ Droplet Digital™ PCR System (Bio-Rad) using specific and reference primers and probes as described by Wu et al. 50 . Data was analyzed using QuantaSoft software (Bio-Rad), which estimated absolute copies of C4 allele-specific DNA templates by comparison to the reference RPP30 template present as two copies per genome.
Risk of schizophrenia in electronic medical records
We utilized de-identified data from the electronic health records of the Partners HealthCare system, which spans multiple academic medical centers in eastern Massachusetts. Reliability of psychiatric phenotypes and medication exposures has previously been demonstrated for genetic 37 and longitudinal outcome studies 51-54 , including pharmacovigilance studies of similar design [55] [56] [57] . Medication data reflected electronic prescribing by any clinician, and included duration of prescription and number of refills. We have previously demonstrated that electronic prescribing is strongly associated with presence of a detectable blood level 58 . Of note, in the present analysis, diagnostic misclassification and medication non-adherence would both be expected to bias results toward the null hypothesis, i.e., no effect of treatment with minocycline on schizophrenia risk. The at-risk cohort was defined as individuals younger than age 18 at index visit without an ICD-9-CM diagnosis of schizophrenia (295.x) or schizoaffective disorder (295.7) who received at least 90 days of continuous antibiotic treatment for acne vulgaris.
Follow-up continued until diagnosis of schizophrenia or schizoaffective disorder, or December 31, 2016, whichever came first. A priori, we required a minimum of 90 days exposure to a given antibiotic, for three reasons. First, this exposure requires documentation of at least two prescriptions, increasing confidence in adherence. Second, very short durations could still reflect other indications for antibiotic use, while treatment for this duration is more typical in acne patients 59 . Finally, the inclusion of only antibiotic-treated patients minimizes risk of confounding by indication (for example, if another chronic infection were associated with schizophrenia risk, or non-antibiotics were preferred in a particular patient subgroup). All analyses were performed using logistic regression, to allow adjustment for potential confounding features including age and sex. Regression with coarsened exact matching 60 was also applied to confirm robustness of association to potential sources of bias by better balancing exposed and unexposed groups. Table S5 . (e) Confocal images of synaptosomes labeled with calcein blue-AM and
